Status:
RECRUITING
Statins and ARBs on Rheumatoid Activity
Lead Sponsor:
Sherief Abd-Elsalam
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
Detailed Description
The study aims at ivestigating and comparing the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
Eligibility Criteria
Inclusion
- Rheumatoid arthritis.
Exclusion
- Pregnant or lactating
- Hepatic or renal impairment.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03770702
Start Date
October 1 2018
End Date
December 1 2026
Last Update
December 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sherief Abd-Elsalam
Tanta, Egypt, 35111